COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)

Since the emergence of the SARS-CoV-2 infection, many recommendations have been made. However, the very nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against cancers and leukemias in children and...

Descripción completa

Detalles Bibliográficos
Autores principales: Baruchel, André, Bertrand, Yves, Boissel, Nicolas, Brethon, Benoit, Ducassou, Stéphane, Gandemer, Virginie, Halfon-Domenech, Carine, Leblanc, Thierry, Leverger, Guy, Michel, Gérard, Petit, Arnaud, Ray-Lunven, Anne-France, Rohrlich, Pierre-Simon, Schneider, Pascale, Sirvent, Nicolas, Strullu, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société Française du Cancer. Published by Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190519/
https://www.ncbi.nlm.nih.gov/pubmed/32387061
http://dx.doi.org/10.1016/j.bulcan.2020.04.003
Descripción
Sumario:Since the emergence of the SARS-CoV-2 infection, many recommendations have been made. However, the very nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against cancers and leukemias in children and adolescents (SFCE) to propose more specific recommendations, even if data for this population are still scarce. They may have to evolve according to the rapid evolution of knowledge on COVID-19.

Ejemplares similares